Good efficacy and tolerability of ustekinumab in a patient with severe psoriasis under haemodialysis.

Abstract

Ustekinumab is indicated for moderate to severe plaque psoriasis in adults who fail to respond to, have a contra-indication for, or are intolerant to conventional systemic therapies. There are limited data on the use of ustekinumab in haemodialysis patients with severe psoriasis. We report a case of successful treatment with ustekinumab in a haemodialysis patient with severe psoriasis.A 34-year-old woman, with a history of hereditary chronic renal insufficiency, was grafted in 2001, and then given [...]